The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants

By Dr. David Edward Marcinko; MBA MEd

SPONSOR: http://www.MarcinkoAssociates.com

***

***

The “Living Dead” of the Investment World

In the vast ecosystem of global finance, investment funds are expected to follow a predictable life cycle: raise capital, deploy it into promising assets, generate returns, and eventually wind down as investments are realized. Yet not all funds complete this journey cleanly. Some become trapped in a state of suspended animation—neither active nor fully dissolved. These are known as zombie funds, a term that captures their eerie persistence and their inability to either grow or die. Though often overlooked, zombie funds represent a significant structural challenge within private equity, venture capital, and other alternative investment sectors.

At their core, zombie funds are investment vehicles that have outlived their intended lifespan but continue to operate because they still hold illiquid, underperforming, or otherwise difficult‑to‑exit assets. Most private investment funds are designed with a fixed term, commonly around ten years. The early years are devoted to deploying capital, while the later years focus on managing and exiting investments. A zombie fund emerges when this timeline breaks down—when the fund reaches or exceeds its contractual end date but remains unable to liquidate its remaining holdings. Instead of winding down, it lingers, often for years, in a state of minimal activity.

Several factors contribute to the creation of zombie funds. The most common is illiquidity. Some assets, particularly distressed companies, niche real estate holdings, or speculative ventures, simply cannot be sold at a reasonable price. Market conditions may deteriorate, buyers may be scarce, or the assets may require additional capital to become viable—capital the fund no longer has. In other cases, the assets themselves may be embroiled in legal disputes, regulatory complications, or operational failures that make divestment slow or impossible.

Another driver is poor performance. When a fund’s portfolio companies fail to meet growth expectations, the general partners (GPs) managing the fund may hesitate to sell them at a loss. Realizing losses can damage the GP’s track record, making it harder to raise future funds. As a result, managers may choose to hold onto struggling assets in the hope that conditions improve, even when such improvement is unlikely. This creates a perverse incentive: the GP may prefer to keep the fund alive—collecting management fees—rather than acknowledge failure.

Fee structures themselves can exacerbate the problem. Many funds charge management fees based on committed capital, not current asset value. Even when the fund’s net asset value has declined significantly, the GP may still receive substantial fees simply for keeping the fund open. This dynamic can create a misalignment between the interests of the GP and those of the limited partners (LPs), who are the investors in the fund. While LPs want their capital returned and the fund closed, GPs may benefit financially from prolonging the fund’s life.

For investors, zombie funds pose several risks. The most obvious is capital entrapment. Money tied up in a zombie fund cannot be redeployed into more productive opportunities. Over time, this opportunity cost can be substantial. Additionally, the remaining assets in a zombie fund are often the weakest performers—those that could not be sold earlier. As a result, the likelihood of meaningful recovery diminishes the longer the fund persists.

Transparency is another concern. Zombie funds often provide limited updates, and valuations may become increasingly opaque as assets age. Without clear information, investors struggle to assess the true value of their holdings or the likelihood of eventual distributions. This uncertainty can erode trust between LPs and GPs, complicating future fundraising efforts across the industry.

Despite these challenges, zombie funds are not always purely negative. In some cases, the extended timeline allows managers to maximize value from difficult assets. A distressed company might eventually recover, or a niche property might find a buyer after market conditions shift. For specialized investors, zombie funds can even present opportunities. Secondary buyers—firms that purchase stakes in existing funds—may acquire positions in zombie funds at steep discounts, betting that the underlying assets will eventually yield returns.

***

***

Still, the broader implications of zombie funds are largely problematic. They tie up capital that could otherwise support innovation, growth, and new ventures. They distort performance metrics within the private investment industry, making it harder for investors to evaluate managers accurately. And they highlight structural weaknesses in fund governance, particularly around incentives and transparency.

Efforts to address the zombie fund problem have grown in recent years. Some LPs push for GP‑led restructurings, in which the fund’s remaining assets are transferred to a new vehicle with revised terms. Others advocate for secondary market solutions, allowing investors to exit their positions even if the fund itself cannot close. Regulatory bodies in some jurisdictions have also begun scrutinizing fee structures and reporting practices to ensure that investors are treated fairly.

Ultimately, zombie funds reflect the inherent uncertainty of investing in illiquid, long‑term assets. Not every bet pays off, and not every fund can follow its intended path. Yet the persistence of zombie funds underscores the need for stronger alignment between managers and investors, clearer communication, and more flexible mechanisms for winding down troubled funds. As the private investment landscape continues to evolve, addressing the challenges posed by zombie funds will be essential to maintaining trust, efficiency, and accountability within the industry.

COMMENTS APPRECIATED

EDUCATION: Books

SPEAKING: Dr. Marcinko will be speaking and lecturing, signing and opining, teaching and preaching, storming and performing at many locations throughout the USA this year! His tour of witty and serious pontifications may be scheduled on a planned or ad-hoc basis; for public or private meetings and gatherings; formally, informally, or over lunch or dinner. All medical societies, financial advisory firms or Broker-Dealers are encouraged to submit an RFP for speaking engagements: CONTACT: Ann Miller RN MHA at MarcinkoAdvisors@outlook.com -OR- http://www.MarcinkoAssociates.com

Like, Refer and Subscribe

***

Filed under: iMBA, Inc. | Tagged: business, finance, Investing, Marcinko, personal-finance, stocks, zombie-funds | Leave a comment »